![]() |
市場調查報告書
商品編碼
1938476
藥局自動化設備市場-全球產業規模、佔有率、趨勢、機會及預測(依產品、通路、地區及競爭格局分類,2021-2031年)Pharmacy Automation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region & Competition, 2021-2031F |
||||||
全球藥局自動化設備市場預計將從 2025 年的 57.3 億美元成長到 2031 年的 96.7 億美元,複合年成長率為 9.11%。
這些電子機械系統旨在實現關鍵藥物管理流程的自動化,例如藥物的儲存、包裝、分發和回收,從而提高醫院和零售環境的營運效率。市場成長的主要驅動力是減少用藥錯誤、應對快速成長的處方箋量以及提高員工生產力的迫切需求。美國衛生系統藥劑師協會 (ASHP) 的數據支持其廣泛應用,報告顯示,到 2024 年,86.1% 的醫院將使用自動發藥櫃作為其維持劑量分發的主要方法。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 57.3億美元 |
| 市場規模:2031年 | 96.7億美元 |
| 複合年成長率:2026-2031年 | 9.11% |
| 成長最快的細分市場 | 自動配藥系統 |
| 最大的市場 | 北美洲 |
儘管呈現正向趨勢,但由於採用機器人系統需要大量資本投入,市場仍面臨許多障礙。小規模醫療機構往往因初始成本高昂以及將其整合到現有醫院資訊系統方面的技術難題而對採用機器人系統猶豫不決。因此,這些財務和基礎設施的挑戰仍然存在,阻礙了資源有限環境下的市場擴張和更廣泛的應用。
減少用藥錯誤和提高病人安全是推動藥局自動化設備普及的關鍵因素。醫療機構正在加速採用這些自動化系統,以消除人工重複操作並確保配藥準確性,從而顯著降低不良用藥事件的風險。這種對安全的重視正在推動自動化工作流程中檢驗技術的應用,以防止配藥錯誤。例如,美國衛生系統藥劑師協會 (ASHP) 於 2024 年 5 月開展的「醫院藥房實踐全國調查」顯示,92.6% 的醫院使用條碼掃描來補充自動配藥櫃中的藥品,這凸顯了這些設備在維護嚴格的安全標準方面發揮的重要作用。
同時,人事費用上升和熟練藥劑師短缺正對市場產生重大影響,迫使該行業採用機器人技術以維持業務連續性。隨著服務需求與勞動力供應之間的差距不斷擴大,各機構正在將日常配藥任務自動化,以最佳化現有員工的工作效率。根據美國國家社區藥劑師協會 (NCPA) 於 2024 年 10 月發布的《2024 年 NCPA 摘要》,67% 的獨立社區藥局業主正面臨嚴重的員工短缺挑戰。這種勞動力短缺正在推動自動化服務提供者的財務成長。例如,Omnicell 公司在 2025 年 2 月發布的 2024 會計年度財務報告中顯示,其年度經常性收入為 5.8 億美元,這印證了各機構越來越依賴自動化基礎設施來緩解勞動力短缺的挑戰。
實施所需的大量資本投入是全球藥局自動化設備市場的一大障礙。機器人系統和自動配藥櫃的高昂初始成本構成了進入門檻,阻礙了其普及,尤其對於預算有限的獨立藥房和小規模醫療機構而言更是如此。此外,技術複雜性以及與現有醫院資訊網路整合的相關成本進一步加劇了這一經濟負擔,導致許多潛在用戶儘管面臨營運方面的諸多益處,仍然選擇推遲或放棄現代化改造計畫。
這些財務限制的影響在近期行業數據中顯而易見。根據美國國家社區藥劑師協會 (NCPA) 發布的《2024 年報告摘要》,獨立社區藥局的毛利率將在 2023 年下降至 19.7%,創該報告發布十年以來的最低水準。在如此嚴峻的財務環境下,藥局管理人員越來越難以證明昂貴自動化技術的投資收益(ROI) 的合理性。因此,資金短缺直接阻礙了藥房在零售領域和資源有限的醫院環境中的市場滲透,從而有效地抑制了該行業的潛在成長速度。
透過向去中心化自動化配藥模式的轉變,醫藥產業正在經歷結構性轉型。這種模式將大批量處方箋配藥作業從零售櫃檯轉移到自動化微型倉配中心。這種中心輻射式配置利用工業機器人處理日常用藥,從而減輕現場工作量,使藥劑師能夠專注於臨床服務而非手動配藥。大型連鎖藥局正積極尋求最佳化其集中處理能力,而這種轉變正獲得顯著推動。根據沃爾格林於2025年5月發布的題為「擴展處方箋微型倉配網路」的新聞稿,該公司微型倉配中心的出貨量同比成長24%,這表明這種集中式配藥架構正在迅速擴張。
同時,採用基於雲端的藥房工作流程平台對於確保整個醫療保健系統的互通性和無縫資料交換至關重要。這些數位生態系統打破了傳統的資訊孤島,實現了跨多個醫療機構的即時庫存可見性和統一的病患記錄。行業領導者正積極利用這一趨勢,建立完全互聯的技術基礎設施,以改善消費者的健康體驗並簡化後端營運。根據《連鎖藥局評論》(Chain Drug Review)2025年6月刊報導,CVS Health宣布將在未來10年內戰略性投資200億美元,以建立一個專注於推動系統範圍內互通性和數位化互動的技術主導平台。
The Global Pharmacy Automation Devices Market is projected to expand from a valuation of USD 5.73 Billion in 2025 to USD 9.67 Billion by 2031, registering a Compound Annual Growth Rate (CAGR) of 9.11%. These electromechanical systems are designed to automate critical medication management processes, including storage, packaging, dispensing, and retrieval, thereby streamlining operations within hospital and retail environments. Market growth is primarily driven by the urgent need to reduce medication errors, manage surging prescription volumes, and enhance workforce productivity. Evidence of widespread acceptance is reflected in data from the American Society of Health-System Pharmacists, which noted in 2024 that 86.1% of hospitals utilized automated dispensing cabinets as the primary method for maintenance dose distribution.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 5.73 Billion |
| Market Size 2031 | USD 9.67 Billion |
| CAGR 2026-2031 | 9.11% |
| Fastest Growing Segment | Automated Medication Compounding Systems |
| Largest Market | North America |
Despite this positive trajectory, the market faces considerable hurdles due to the significant capital investment required for deployment. The prohibitive initial costs of robotic systems, along with the technical difficulties associated with integrating them into existing hospital information architectures, frequently discourage adoption by smaller healthcare institutions. Consequently, these financial and infrastructure-related challenges act as persistent barriers, limiting the market's reach in resource-constrained settings and impeding broader penetration.
Market Driver
The imperative to minimize medication errors and enhance patient safety serves as a primary catalyst for the adoption of pharmacy automation devices. Healthcare institutions are increasingly integrating these automated systems to eliminate manual redundancies and ensure dispensing accuracy, significantly reducing the risk of adverse drug events. This commitment to safety is driving the implementation of verification technologies within automated workflows to prevent distribution failures. For instance, the 'National Survey of Pharmacy Practice in Hospital Settings' by the American Society of Health-System Pharmacists in May 2024 revealed that 92.6% of hospitals employed barcode scanning while restocking automated dispensing cabinets, highlighting the pivotal role these devices play in upholding strict safety standards.
Simultaneously, the market is significantly influenced by rising labor costs and a shortage of skilled pharmacists, compelling the industry to deploy robotics to maintain operational continuity. As the gap between service demand and workforce availability widens, organizations are automating routine dispensing tasks to optimize the efficiency of existing staff. The '2024 NCPA Digest' published by the National Community Pharmacists Association in October 2024 indicated that 67% of independent community pharmacy owners faced substantial difficulty in filling staff positions. This workforce strain has fueled financial growth for automation providers; Omnicell, Inc., for example, reported an Annual Recurring Revenue of $580 million for the fiscal year ending 2024 in February 2025, underscoring the increasing reliance on automated infrastructure to mitigate labor challenges.
Market Challenge
The substantial capital expenditure required for implementation constitutes a severe obstruction to the Global Pharmacy Automation Devices Market. High upfront costs for robotic systems and automated dispensing cabinets create a prohibitive barrier to entry, particularly for independent pharmacies and smaller healthcare facilities operating on restricted budgets. This financial burden is compounded by the technical complexity and associated costs of integrating these systems with legacy hospital information networks, leading many potential adopters to delay or forgo modernization efforts despite the operational benefits.
The impact of these financial constraints is evident in recent industry data. According to the National Community Pharmacists Association (NCPA) 2024 Digest, the gross profit margin for independent community pharmacies fell to 19.7% in 2023, marking the lowest point in the report's ten-year history. Such constricted fiscal environments make it increasingly difficult for facility managers to justify the Return on Investment (ROI) for expensive automation technologies. Consequently, this lack of available capital directly stalls market penetration in the retail sector and resource-limited hospital settings, effectively capping the industry's potential growth rate.
Market Trends
The industry is witnessing a structural transformation through the shift toward decentralized automated dispensing models, which relocate high-volume prescription fulfillment from retail counters to automated micro-fulfillment centers. This hub-and-spoke configuration leverages industrial-grade robotics to process maintenance medications, thereby alleviating on-site workload constraints and allowing pharmacists to focus on clinical services rather than manual filling. This transition is gaining significant momentum among major pharmacy chains seeking to optimize centralized throughput capabilities. According to Walgreens, May 2025, in the 'Walgreens Expands Prescription Microfulfillment Network' press release, the company reported a 24% year-over-year increase in shipped volumes from its micro-fulfillment centers, highlighting the rapid scaling of this centralized dispensing architecture.
Simultaneously, the adoption of cloud-based pharmacy workflow platforms is becoming critical for ensuring interoperability and seamless data exchange across the healthcare continuum. These digital ecosystems dismantle traditional information silos, enabling real-time inventory visibility and unified patient records that span multiple care settings. Industry leaders are aggressively capitalizing on this trend to create fully connected technology infrastructures that enhance the consumer health experience and streamline backend operations. According to Chain Drug Review, June 2025, in the article 'CVS Health plans to spend $20B to enhance the consumer experience', CVS Health announced a strategic investment of $20 billion over the next decade to build a technology-driven platform focused on advancing system-wide interoperability and digital engagement.
Report Scope
In this report, the Global Pharmacy Automation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Pharmacy Automation Devices Market.
Global Pharmacy Automation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: